A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

NCT00734474 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1202

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2189265
DRUG: Sitagliptin
DRUG: Placebo solution
DRUG: Placebo tablet
DRUG: Metformin

Sponsor

Eli Lilly and Company

Collaborators

[object Object]
[object Object]
[object Object]